U.S. researchers have found that a common Alzheimer's drug may bring improved driving skills in those with mild Alzheimer's disease.

It has been reported that Lori Daiello of the Rhode Island Hospital in Providence and colleagues looked at driving-related effects of cholinesterase inhibitors on patients with mild Alzheimer's disease.

Published in the Journal of Clinical Psychopharmacology, the study reported patients taking the drug showed improvement in scores on computerized tests of cognitive skills necessary for driving, including executive function, visual attention and a simulated driving task.

Daiello said in a statement, "Because many patients receiving a diagnosis of Alzheimer's disease continue to drive in its early stages, it is critical that we assess driving safety among this population and identify therapies that may improve driving abilities. The results show an improvement in the skills that will impact a patient's ability to perform tasks associated with safe driving." (With Inputs from Agencies)